Leap Therapeutics (LPTX) Misses Q2 EPS by 40c

Leap Therapeutics (NASDAQ: LPTX) reported Q2 EPS of ($0.40), $0.40 worse than the analyst estimate of $0.00.

For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• 22nd Century Group files prospectus for warrant share resale